Point72 Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Point72 Asset Management's WST Position: Q3 2026 in Review
Point72 Asset Management increased its West Pharmaceutical (WST) stake by 13% in Q3 2026, buying an estimated $13.2M and bringing the position to 320,705 shares worth $119M. The position accounts for 0.13% of the portfolio, ranked #172.
Point72 Asset Management first reported a position in WST in Q2 2019 and has held it in 23 quarters since. The position peaked at $173M in Q3 2025. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Point72 Asset Management held 320,705 shares of West Pharmaceutical worth $119M as of Q3 2026.
- Point72 Asset Management bought 37,309 West Pharmaceutical shares in Q3 2026, an estimated $13.2M.
- West Pharmaceutical made up 0.13% of Point72 Asset Management's portfolio in Q3 2026, its #172 holding.
- Point72 Asset Management first reported a position in West Pharmaceutical in Q2 2019 and has held it in 23 quarters since.
- Point72 Asset Management's West Pharmaceutical position peaked at $173M in Q3 2025.
- 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.